This new and improved treatment option has shown to be highly effective in clinical trials, with a success rate of over 80%
Patients are left with the appetite suppression and none of the scaffolding around it, which is why we're now seeing predictable issues with muscle loss, nutrient deficiencies, and weight regain when people come off
That is generally described as a more physiologic pattern than the pharmacologic square-wave of exogenous HGH, and it is one reason secretagogues were pursued as candidate tools to enhance GH secretion in disease and aging in the first place
Abruptly discontinuing semaglutide or similar GLP-1 receptor agonists can trigger rapid appetite return and weight rebound within weeksresearch shows patients may regain 50% of lost weight within one year if therapy stops without transition planning
It is a decision-support layer, not a prescription engine
** The result depends on individual metabolism